Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China · Delayed Price · Currency is CNY 9.91
-0.26 (-2.56%)
May 12, 2026, 3:04 PM CST
SHE:002873 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 8.42 | 9.11 | 52.32 | 80.87 | 111.52 | 100.61 |
Depreciation & Amortization | 37.68 | 37.68 | 37.38 | 23.34 | 25.45 | 22.81 |
Other Amortization | 6.8 | 6.8 | 1.61 | 1.47 | 1.28 | 2.69 |
Loss (Gain) From Sale of Assets | 0.78 | 0.78 | -18.9 | - | 0.02 | 0.1 |
Asset Writedown & Restructuring Costs | 0.16 | 0.16 | 0.71 | 0.07 | 0.12 | 0.37 |
Loss (Gain) From Sale of Investments | 0.02 | 0.02 | -0.02 | 0.72 | 0.4 | - |
Provision & Write-off of Bad Debts | -1.38 | -1.38 | 2.61 | -0.27 | 0.52 | 1.73 |
Other Operating Activities | 49.75 | 21.42 | 23.33 | 16.11 | 15.23 | 17.52 |
Change in Accounts Receivable | 49.95 | 49.95 | -38.03 | 7 | -20.18 | -8.45 |
Change in Inventory | -30.23 | -30.23 | 35.8 | -1.2 | -66.75 | -40.35 |
Change in Accounts Payable | -11.11 | -11.11 | -10 | -52.08 | 1.79 | 25.94 |
Operating Cash Flow | 111.37 | 83.73 | 88.13 | 77.78 | 75.82 | 124.3 |
Operating Cash Flow Growth | 33.36% | -4.99% | 13.30% | 2.59% | -39.00% | -29.28% |
Capital Expenditures | -60.07 | -51.59 | -61.45 | -101.7 | -129.2 | -105.69 |
Sale of Property, Plant & Equipment | 2.14 | 2.14 | 15.08 | 5 | 0.03 | 0.08 |
Cash Acquisitions | -2.99 | -2.99 | - | - | - | - |
Investment in Securities | -40 | -40 | 0 | 0 | 50 | -112 |
Other Investing Activities | 0.01 | 0.01 | - | - | - | - |
Investing Cash Flow | -100.91 | -92.43 | -46.37 | -96.7 | -79.17 | -217.61 |
Long-Term Debt Issued | - | 532.75 | 680 | 506 | 347 | 273 |
Total Debt Issued | 374.36 | 532.75 | 680 | 506 | 347 | 273 |
Long-Term Debt Repaid | - | -421.63 | -577.29 | -404 | -278 | -418.63 |
Total Debt Repaid | -279.81 | -421.63 | -577.29 | -404 | -278 | -418.63 |
Net Debt Issued (Repaid) | 94.55 | 111.12 | 102.71 | 102 | 69 | -145.63 |
Issuance of Common Stock | - | - | - | - | - | 27.81 |
Repurchase of Common Stock | -5.44 | -5.44 | -129.48 | -2.99 | -3.1 | -15.02 |
Common Dividends Paid | -32.2 | -41.42 | -35.06 | -42.53 | -34.35 | -30.33 |
Other Financing Activities | 0.01 | - | - | - | - | -1.12 |
Financing Cash Flow | 56.91 | 64.25 | -61.83 | 56.48 | 31.54 | -164.3 |
Foreign Exchange Rate Adjustments | - | - | - | 0 | - | - |
Net Cash Flow | 67.37 | 55.56 | -20.07 | 37.57 | 28.19 | -257.61 |
Free Cash Flow | 51.29 | 32.14 | 26.68 | -23.92 | -53.38 | 18.61 |
Free Cash Flow Growth | 112.24% | 20.48% | - | - | - | -82.71% |
Free Cash Flow Margin | 6.98% | 4.29% | 3.11% | -2.51% | -4.91% | 1.92% |
Free Cash Flow Per Share | 0.22 | 0.14 | 0.12 | -0.10 | -0.22 | 0.08 |
Cash Income Tax Paid | 81.08 | 86.33 | 79.86 | 97.63 | 117.84 | 112 |
Levered Free Cash Flow | 51.51 | 5.56 | -6.5 | -31.37 | -97.92 | -17.28 |
Unlevered Free Cash Flow | 62.61 | 16.66 | 4.48 | -23.99 | -91.24 | -6.9 |
Change in Working Capital | 9.15 | 9.15 | -10.9 | -44.54 | -78.71 | -21.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.